TANDEM DIABETES CARE INC
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Does Libre 3 Plus Integration Expand Tandem’s Interoperability Edge And Bull Case For TNDM?
In July 2026, Tandem Diabetes Care announced that its t:slim X2 insulin pump with Control-IQ+ technology is now compatible with Abbott’s FreeStyle Libre 3 Plus CGM in the UK, Switzerland, Sweden, Finland, and Italy, expanding CGM choice for pump users and enabling 15-day sensors with minute-by-minute glucose data. This integration strengthens Tandem’s ecosystem by pairing its advanced AutoBolus-enabled AID algorithm with one of Europe’s most widely used CGM platforms, potentially broadening...
Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion?
Tandem Diabetes Care (TNDM) is back in focus after announcing that its t:slim X2 insulin pump with Control-IQ+ technology now connects with Abbott’s FreeStyle Libre 3 Plus CGM across five European countries. See our latest analysis for Tandem Diabetes Care. The Abbott tie up comes as Tandem Diabetes Care’s 1 year total shareholder return is down 1.15%, while the share price has fallen 28.49% year to date to $15.41. This suggests recent momentum has faded despite the product expansion...
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets
SAN DIEGO, July 01, 2026--The t:slim X2™ insulin pump from Tandem Diabetes Care is now compatible with Abbott’s FreeStyle Libre 3 Plus CGM sensor in five EU countries.
Congressional Trades in $TNDM
Insider Trades (Form 4)
Allen Dick
Key People
Allen Dick
Insider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro